Clinical Trial Update: High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing high-dose IV N-acetylcysteine with iloprost for early, rapidly progressive diffuse systemic sclerosis; the study is Phase 2/Phase 3 wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis Diffuse Type

Drugs mentioned

• Iloprost (iloprost)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Università Politecnica delle Marche | Conditions: Scleroderma, Diffuse | Phase 2, Phase 3 | Status: UNKNOWN